VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 377 filers reported holding VANECK VECTORS ETF TR in Q3 2017. The put-call ratio across all filers is 1.17 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $497 | +27.8% | 18,453 | +42.8% | 0.20% | +8.3% |
Q2 2023 | $389 | -1.3% | 12,923 | +6.2% | 0.18% | -6.7% |
Q1 2023 | $394 | +9.1% | 12,173 | -3.4% | 0.19% | +2.1% |
Q4 2022 | $361 | -99.9% | 12,598 | +3.3% | 0.19% | +11.8% |
Q3 2022 | $294,000 | -12.0% | 12,193 | 0.0% | 0.17% | -6.1% |
Q2 2022 | $334,000 | -26.8% | 12,193 | +2.5% | 0.18% | -15.5% |
Q1 2022 | $456,000 | +30.7% | 11,893 | +9.2% | 0.21% | +31.5% |
Q4 2021 | $349,000 | +4.8% | 10,893 | -3.5% | 0.16% | -4.1% |
Q3 2021 | $333,000 | -20.3% | 11,284 | -8.2% | 0.17% | -19.1% |
Q2 2021 | $418,000 | -4.6% | 12,296 | -8.8% | 0.21% | -8.7% |
Q1 2021 | $438,000 | +0.7% | 13,478 | +11.6% | 0.23% | -5.8% |
Q4 2020 | $435,000 | -19.7% | 12,078 | -12.7% | 0.24% | -25.9% |
Q3 2020 | $542,000 | +5.0% | 13,833 | -1.6% | 0.33% | +0.9% |
Q2 2020 | $516,000 | +67.0% | 14,056 | +4.7% | 0.32% | +46.4% |
Q1 2020 | $309,000 | -15.8% | 13,431 | +7.2% | 0.22% | +5.2% |
Q4 2019 | $367,000 | +10.9% | 12,533 | +1.2% | 0.21% | +3.4% |
Q3 2019 | $331,000 | +4.7% | 12,379 | 0.0% | 0.20% | +6.2% |
Q2 2019 | $316,000 | +7.5% | 12,379 | -5.7% | 0.19% | +5.5% |
Q1 2019 | $294,000 | +10.5% | 13,133 | +4.0% | 0.18% | +4.0% |
Q4 2018 | $266,000 | +35.0% | 12,633 | +18.8% | 0.18% | +59.1% |
Q3 2018 | $197,000 | -16.9% | 10,633 | 0.0% | 0.11% | -17.9% |
Q2 2018 | $237,000 | -6.7% | 10,633 | -7.0% | 0.13% | -11.3% |
Q1 2018 | $254,000 | -32.1% | 11,433 | -29.0% | 0.15% | -44.7% |
Q4 2017 | $374,000 | -1.3% | 16,102 | -2.4% | 0.27% | -7.8% |
Q3 2017 | $379,000 | -0.8% | 16,502 | -7.3% | 0.30% | -1.3% |
Q2 2017 | $382,000 | -6.1% | 17,802 | -0.3% | 0.30% | -9.9% |
Q1 2017 | $407,000 | +9.1% | 17,852 | 0.0% | 0.33% | +2.8% |
Q4 2016 | $373,000 | -24.0% | 17,852 | -3.9% | 0.32% | -26.2% |
Q3 2016 | $491,000 | -7.9% | 18,567 | -3.4% | 0.44% | -9.9% |
Q2 2016 | $533,000 | – | 19,217 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |